Calcium carbonate tablets
Function and Efficacy
1. Drinking a lot of alcoholic and caffeinated beverages and smoking a lot will inhibit the absorption of oral calcium. 2. Eating a lot of fiber-rich foods can inhibit calcium absorption because calcium combines with cellulose to form compounds that are not easily absorbed. 3. When this product is used together with phenytoin sodium and tetracycline, the absorption of both is reduced. 4. Vitamin D, contraceptives, and estrogen can increase calcium absorption. 5. When aluminum-containing antacids are taken with this product, aluminum absorption increases. 6. When used with calcium channel blockers (such as nifedipine), blood calcium can be significantly increased to above normal, but the effect of verapamil hydrochloride is reduced. 7. When this product is used in combination with thiazide diuretics, hypercalcemia is prone to occur (due to increased renal tubular calcium reabsorption). 8. When this product is used in combination with potassium-containing drugs, attention should be paid to arrhythmias. 9. When used in combination or cross-application with laxative antacids such as magnesium oxide, it can reduce side effects such as belching and constipation.
Ingredients
The main component is calcium carbonate.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Calcium carbonateIngredients |
1. Drinking a lot of alcoholic and caffeinated beverages and smoking a lot will inhibit the absorption of oral calcium preparations; 2. Eating a lot of fiber-rich foods can inhibit calcium absorption, because calcium combines with cellulose to form compounds that are not easily absorbed; 3. When used with phenytoin sodium and tetracycline, the absorption of both is reduced; 4. Vitamin D, contraceptives, and estrogen can increase calcium absorption; 5. When aluminum-containing antacids are taken with this product, aluminum absorption increases; 6. When used with calcium channel blockers (such as nifedipine), blood calcium can be significantly increased to above normal, but the effect of verapamil hydrochloride is reduced; 7. When used with thiazide diuretics, hypercalcemia is prone to occur (due to increased renal tubular calcium reabsorption); 8. When used with potassium-containing drugs, attention should be paid to arrhythmias; 9. When used with laxative antacids such as magnesium oxide or cross-application, side effects such as belching and constipation can be reduced. More |
471-34-1 | 43 |
Appearance
This product is a white film-coated tablet, which appears off-white after removing the coating.
Indication
This product is a calcium supplement used to prevent and treat calcium deficiency diseases such as osteoporosis, tetany, bone dysplasia, rickets, and calcium supplementation for pregnant and lactating women and menopausal women.
Usage and Dosage
Oral administration: 200-1200 mg (calculated as Ca2+) per day, divided into two doses. You can also supplement according to the needs of the human body and the supply of dietary calcium, or follow the doctor's advice.
Adverse Reactions
1. Belching and constipation. 2. Occasionally, milk-alkali syndrome may occur, manifested as hypercalcemia, alkalosis and renal insufficiency. (Caused by taking milk and calcium carbonate, or calcium carbonate alone). 3. Long-term excessive use may cause rebound increase in gastric acid secretion and may cause hypercalcemia.
Precautions
1. Use with caution in combination with digitalis drugs. 2. Use with caution in patients with gastric or duodenal ulcers.
Special Population Medication
Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.
Drug Interactions
Not yet clear.
Storage
Sealed, store in a dry place.
Packaging Specification
0.25g (calculated as Ca) (plain tablet)
Validity Period
24 months
Manufacturer
Harbin Pharmaceutical Group Pharmaceutical Factory No.6
-
Founded in:
1994-05-20 -
Address:
No. 326, Nanzhi Road, Daowai District, Harbin, Xingye East Road, Limin Economic and Technological Development Zone, Harbin -
Tax NO.:
912301001270449678 -
Registered Funds:
- -
Website:
-
Email: